In the medical industry, the in vitro diagnostics (IVD) market holds a pivotal position and its development trends have always been closely monitored. Entering 2025, the IVD diagnostic market presents many new changes and trends, and whether the demand for reagent raw materials will surge has become a hot topic in the industry. This issue not only concerns the production and operation of IVD enterprises, but also has a profound impact on the development of the entire industry chain.

enzyme preparation

1、 Growth of IVD diagnostic market size

The global IVD market is steadily expanding in size. The global market size for in vitro diagnostic products is expected to reach approximately $81.7 billion in 2024, and is projected to climb to $109.2 billion by 2031, with a compound annual growth rate of 4.3% from 2025 to 2031. The position of the Chinese market in the global IVD market is becoming increasingly important, and the growth momentum of the domestic market is strong. In 2024, the market size of IVD raw materials in China will reach 5.165 billion yuan, and the global market size will be 27.185 billion yuan. It is expected that the global IVD raw material market will grow at a compound annual growth rate of 8.45% during the forecast period, and the total size of the global IVD raw material market will reach 44.233 billion yuan by 2030.  

There are multiple driving factors behind market growth. On the one hand, the prevalence of chronic and infectious diseases is on the rise worldwide. Take diabetes as an example. With the change of people's lifestyle and the intensification of the aging society, the number of diabetes patients is increasing, and the demand for blood glucose detection and other IVD diagnostic products continues to rise, which drives the demand for reagent raw materials to grow. On the other hand, advances in diagnostic technology are also a key factor. As molecular diagnostic technology develops from traditional PCR technology to more advanced high-throughput sequencing technology, each technological innovation leads to the birth of new diagnostic reagents, and the demand for new reagent raw materials also arises accordingly. The growing demand for personalized healthcare cannot be ignored. Doctors need more accurate diagnostic results to develop personalized treatment plans for patients, which increases the use of IVD diagnostic reagents and drives the demand for reagent raw materials.  

2、 The impact of IVD diagnostic technology development on the demand for reagent raw materials

（1） Innovation in Molecular Diagnostic Technology

In recent years, significant progress has been made in the field of molecular diagnostics, such as the gradual maturity of third-generation sequencing technology. Compared with traditional sequencing technology, third-generation sequencing technology has advantages such as long read length and no need for PCR amplification. It can more accurately detect gene sequences and has broad applications in early screening of tumors and diagnosis of genetic diseases. The development of this technology has greatly increased the demand for reagents and raw materials that are compatible with it. For example, third-generation sequencing requires special DNA polymerases and other raw materials, and the research and production of these materials have become key to meeting market demand. Moreover, with the promotion and application of technology, the clinical demand for detection volume has increased, and the demand for reagent raw materials will continue to rise.  

（2） Upgrade of immune diagnostic technology

Immunodiagnostic technology is constantly upgrading, evolving from traditional enzyme-linked immunosorbent assay (ELISA) to more advanced technologies such as chemiluminescence immunoassay and time-resolved fluorescence immunoassay. These new technologies have higher sensitivity and specificity, and are widely used in infectious disease diagnosis, tumor marker detection, and other fields. Taking chemiluminescence immunoassay as an example, its detection process requires specific luminescent substrates, antibodies, and other raw materials. With the popularization of chemiluminescence immunoassay technology in clinical practice, the demand for these raw materials is showing a rapid growth trend.

（3） Popularization of POCT technology

POCT technology has been widely used in primary healthcare, home testing, and other fields due to its fast and convenient characteristics. The production of POCT products requires various reagent raw materials, such as buffer solutions, markers, antibodies, etc. With the continuous expansion of the POCT market, the demand for these reagent raw materials is also increasing. And due to the increasing emphasis on health management, POCT products will be more widely used in the detection of chronic diseases such as blood glucose, blood lipids, and blood pressure in the future, which will further stimulate the growth of demand for reagent raw materials.

2、 Market competition pattern and demand for reagent raw materials

（1） Scale effect and raw material demand of large enterprises

In the IVD market, large enterprises dominate the market competition with their brand advantages, technological strength, and market share. These large enterprises usually have a well-established industrial chain layout and large-scale production capacity. In order to maintain production stability and product quality consistency, large enterprises have a huge and relatively stable demand for reagent raw materials.

（2） Differentiated competition and raw material demand of small and medium-sized enterprises

Small and medium-sized enterprises often seek development space through differentiated competition strategies when facing competition from large enterprises. Some small and medium-sized enterprises focus on niche markets and develop distinctive IVD diagnostic products, such as rapid detection reagents for specific diseases. The development and production of this differentiated product require specific reagent raw materials. In order to establish themselves in the market, small and medium-sized enterprises will continuously invest in research and development resources, improve product performance, which will also drive the growth of demand for related specialty reagent raw materials. However, due to limited funds and scale, small and medium-sized enterprises are more sensitive to raw material prices and tend to prefer products with high cost-effectiveness when purchasing raw materials.  

chromogenic substrate

As a manufacturer of IVD reagent raw materials, Hubei Xindesheng has significant advantages in the industry in producing biological buffering agents, color reagents, enzyme preparation raw materials, luminescent reagents, etc. Xindesheng has established a strict quality control system, with layers of checks from raw material procurement to finished product delivery. Its products are widely used in scientific research and clinical diagnosis fields, and have gained recognition from numerous customers. There is also room for growth in the demand for IVD reagent raw materials. If you have any purchasing needs, please feel free to contact us at any time!